China Independent Clinical Laboratory Industry Report, 2016-2020

Publisher Name :
Date: 21-Sep-2016
No. of pages: 135
Inquire Before Buying

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory market size has been growing radically in recent years, reaching about RMB6.5 billion with a year-on-year increase of 37.4% in 2015; it is expected to grow rapidly at a rate of 30%-40% over the next three to five years and report RMB29.2 billion in 2020.

There are approximately200 independent clinical laboratory enterprises in China, mainly comprehensive diagnostic chains and special diagnostic enterprises. KingMed Diagnostics, Dian Diagnostics, ADICON Clinical Laboratories, and DaAn Health (invested by Da An Gene), which hold a combined market share of 70% and all adopt chain-based model of comprehensive diagnostic services. By the end of 2015, the four enterprises separately had 31, 26, 20 and 8 independent clinical laboratories. While expanding clinical laboratory services actively, all companies are deploying " laboratory +" industrial chain vigorously.

As a titan in China independent clinical laboratory industry, KingMed Diagnostics earned the revenue of RMB2.5 billion to RMB3 billion in 2015 with 40% market share. In the past two years, KingMed Diagnostics has been involved in production and sale of in vitro diagnostic products through acquisitions and independent R & D; moreover, it has made layout on "laboratory + Internet" services by acquiring GoHeath (Guangzhou Jinzhun), access to Tmall’s online pharmacies, etc..

Second to KingMed Diagnostics, Dian Diagnostics gained the revenue of RMB1.079 billion from independent clinical laboratory in 2015. In recent years, the company has implemented the strategy of horizontal expansion, vertical digging, technological innovation and industrial chain integration aggressively. It has arranged the " diagnosis +" ecosystem which refers to the expansion of other related services such as health management, judicial diagnostics, medicine CRO, cold chain logistics and mobile health with a focus on "diagnostic services + products". Since November 2015, the company has acquired Freda,Yuanding, ShengshiKehua, Faith Medical, Kingpe and many other high-quality IVD distributors for over RMB1 billion totally. In 2015, the company launched a new mode for chain expansion of physical examination services -- a health management center (Hangzhou Full-process International Health Medical Management Center Co., Ltd.) established with Hangzhou Jiebai, Baida Group. Meanwhile, Dian Diagnostics signed strategic cooperation agreements with The Johns Hopkins Hospital and AliHealth respectively to explore the "diagnosis + Internet" business mode energetically. At the beginning of 2016, Dian Diagnostics collaborated with Tigermed to set up a joint venture -- Shanghai Teddy Medical Institute Co., Ltd., marking the former’s foray into pharmaceutical CRO.

The third-ranked ADICON Clinical Laboratories which still enjoys superiority in East China has not realized the distribution of nationwide chain operation, but its special laboratory items have showed strong competitiveness. The company is not only authorized by the global pharmaceutical giant Roche to become "Roche’s Demonstration Laboratory in China", but also cooperates with Siemens Healthineers, Japan SRL, South Korea SCL, France Bio Mérieux, etc. in medical diagnostics.

Being bullish about the prospects of the Chinese independent clinical laboratory market, a number of small and medium Chinese independent clinical laboratory companies have drawn or plan to draw support fromthe capital market to further expand the clinical laboratory market. In 2014-mid-2016, Surexam Biotechnology, Shanghai Labway, Beijing Lepu, Shanghai Biotecan, Jiangsu Superbio, Beijing Lawke and other companies went public at NEW OTCBB in China. Wherein, Jiangsu Superbio witnessed the fastest revenue growth in clinical laboratory, namely the year-on-year surge of 161.0% in 2015; Shanghai Biotecan took the second place with the CAGR of 92.1% in 2013-2015. Shanghai Labway Clinical Laboraory obtained the clinical laboratory revenue of RMB127.8 million in 2015, but the revenue growth has slowed down due to the construction and expansion of laboratories in recent years.

China Independent Clinical Laboratory Industry Report, 2016-2020 highlights the followings:


  • Policy environment, international market, development status, and competitive landscape of China’s independent clinical laboratory industry;

  • Upstream and downstream markets of China’s independent clinical laboratory industry and their impacts;

  • Operation, and independent clinical laboratory business of 19 relevant enterprises in China;

  • Development outlook of China’s independent clinical laboratory industry in 2016-2020 and operational comparison among key players.

China Independent Clinical Laboratory Industry Report, 2016-2020

Table of Contents

1. Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain

2. Overview of China Independent Clinical Laboratory Industry
2.1 Policy Environment
2.1.1 Access Policy
2.1.2 Industry Policy
2.2 International Market
2.2.1 Status Quo
2.2.2 Benchmarking Enterprises
2.3 Development
2.4 Competitive Landscape

3. Upstream and Downstream Markets of China Independent Clinical Laboratory Industry
3.1 Upstream Market
3.1.1 Status Quo
3.1.2 Competition Pattern
3.2 Downstream Market
3.2.1 Independent Clinical Laboratory Market Sees Huge Capacity
3.2.2 Healthcare Reform Boosts the Rapid Development of Independent Clinical Laboratory Market
3.2.3 Demand Diversification Promotes the Upgrading of Independent Clinical Laboratory Industry
3.2.4 Healthcare Demand Growth Propels the Independent Clinical Laboratory Forward Faster
3.2.5 Internet Will Stimulate the Business Model Upgrade of Independent Clinical Laboratory Industry

4. Key Players
4.1 KingMed Diagnostics
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D and Investment
4.1.6 Independent Clinical Laboratory
4.1.7 Client and Supplier
4.1.8 Forecast and Outlook
4.2 ADICON
4.2.1 Profile
4.2.2 Independent Clinical Laboratory
4.2.3 Development
4.3 Dian Diagnostics
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Independent Clinical Laboratory
4.3.7 Client and Supplier
4.3.8 Forecast and Outlook
4.4 DAAN Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D and Investment
4.4.6 Independent Clinical Laboratory
4.4.7 Client and Supplier
4.4.8 Forecast and Outlook
4.5 Shanghai Labway Clinical Laboratory Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Independent Clinical Laboratory
4.5.7 Client and Supplier
4.5.8 Forecast and Outlook
4.6 NYMPHAVN Biotechnology
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Independent Clinical Laboratory
4.6.7 Forecast and Outlook
4.7 SurExam Bio-Tech Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D and Investment
4.7.6 Independent Clinical Laboratory
4.7.7 Client and Supplier
4.7.8 Forecast and Outlook
4.8 Ningbo Medicalsystem Biotechnology Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 R&D and Investment
4.8.6 Independent Clinical Laboratory
4.8.7 Client and Supplier
4.8.8 Forecast and Outlook
4.9 Beijing Lawke Health Laboratory Co., Ltd.
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 Forecast and Outlook
4.10 Beijing Lepu Gene Technology Co.,Ltd.
4.10.1 Profile
4.10.2 Operation
4.10.3 Gross Margin
4.10.4 Forecast and Outlook
4.11 Shanghai Biotecan Pharmaceuticals Co., Ltd.
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Independent Clinical Laboratory
4.11.6 Forecast and Outlook
4.12 Jiangsu Superbio Life Science Co., Ltd.
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Client and Supplier
4.12.6 Forecast and Outlook
4.13 Other Enterprises
4.13.1 Kindstar Global
4.13.2 Xiamen Amoy Diagnostics Co., Ltd.
4.13.3 CapitalBio Corporation
4.13.4 Beijing Adinovo Technologies Co., Ltd.
4.13.5 Beijing Deyi Diagnostics Technology Co., Ltd.
4.13.6 IPE Biotechnology Co., Ltd.
4.13.7 Centre Testing International

5. Forecast and Outlook
5.1 Industry Development
5.2 Operation Comparison between Enterprises
5.2.1 Revenue
5.2.2 Gross Margin

List of Charts

Independent Clinical Laboratory Industry Chain
Comparison of Independent Clinical Laboratory Undertakers between China and USA
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2016
Market Share of Independent Clinical Laboratories in Major Countries
U.S. Independent Clinical Laboratory Market Share by Test Item
U.S. Clinical Laboratory Market Share by Demand Side
Revenue and Net Income of Quest, 2009-2016
Revenue of Quest Diagnostics by Business, 2014-2015
Major M&As of Quest Diagnostics, 2006-2015
Revenue and Operating Income of LabCorp, 2010-2016
Revenue Breakdown of LabCorp by Business, 2013-2016
Major M&As of LabCorp, 2007-2015
Market Scale of independent clinical laboratory industry in China,2013-2016
Revenue CAGR of Some Independent Clinical Laboratory Enterprises in China, 2012-2015
Market Share of Major Enterprises in China’s Independent Clinical Laboratory Industry, 2015
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2015
Development History of In Vitro Diagnostic Industry in China
Market Size of In Vitro Diagnostic Industry in China, 2009-2015
Market Structure of In Vitro Diagnostic Reagent Industry in China, 2015
Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
Competition Pattern of Diagnostic Reagent Industry in China
IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013-2015
Business Revenue and Inspection Revenue of Public Hospitals in China, 2014
Per Capita Inspection Fees and % of Outpatient Expenses of Outpatients in Chinese Hospitals, 2010-2014
Per Capita Inspection Fees and % of Hospitalization Expenses of Inpatients in Chinese Hospitals, 2010-2014
Business Revenue and Inspection Revenue of Public Hospitals in China by Type of Visit, 2014
Medical Services of Health Agencies in China, 2012-2015
Number of Medical Institutions in China, 2012-2015
Health Expenditure and % of GDP in China, 1980-2015
Per Capita Health Expenditure and YoY Growth in China, 2006-2015
Revenue and Net Income of KingMed Diagnostics, 2012-2015
Revenue Breakdown of KingMed Diagnostics by Business, 2012-2015
Revenue Breakdown of KingMed Diagnostics by Region, 2012-2015
Gross Margin of KingMed Diagnostics by Business, 2012-2015
R&D Costs and % of Total Revenue of KingMed Diagnostics, 2012-2015
Proposed Fundraising & Investment Projects and Value of KingMed Diagnostics, 2016
Distribution of Independent Clinical Laboratories of KingMed Diagnostics, as of June 2016
Capacity and Output of KingMed Diagnostics (by Business), 2014-2015
Service Prices of KingMed Diagnostics (by Business), 2012-2015
Revenue of Dian Diagnostics from Top 5 Clients and % in Total Revenue, 2012-2015
Revenue of KingMed Diagnostics from Top 5 Clients and % of Total Revenue, 2014-2015
Procurement of KingMed Diagnostics from Top 5 Suppliers and % of Total Procurement, 2014-2015
Revenue and Net Income of KingMed Diagnostics, 2015-2020
Revenue and Net Income of Dian Diagnostics, 2010-2016
Revenue Breakdown of Dian Diagnostics by Product, 2010-2016
Revenue Breakdown of Dian Diagnostics by Region, 2009-2016
Gross Margin of Dian Diagnostics, 2010-2016
Gross Margin of Dian Diagnostics by Product, 2010-2015
R&D Costs and % of Total Revenue of Dian Diagnostics, 2010-2016
Dian Diagnostics’ Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2016
Revenue of Dian Diagnostics’ Top 5 Clients and % in Total Revenue, 2011-2016
Revenue of Dian Diagnostics from Top 5 Clients and % of Total Revenue, 2015-2016
Procurement of Dian Diagnostics’ Top 5 Suppliers and % in Total Procurement, 2011-2016
Procurement of Dian Diagnostics’ Top 5 Suppliers and % in Total Procurement, 2015-2016
Revenue and Net Income of Dian Diagnostics, 2015-2020E
Revenue and Net Income of Da An Gene, 2010-2016
Revenue Breakdown of Da An Gene by Business, 2010-2016
Revenue Breakdown of Da An Gene by Region, 2010-2016
Gross Margin of Da An Gene, 2010-2016
Gross Margin of Da An Gene by Business, 2010-2016
R&D Costs and % of Total Revenue of Da An Gene, 2011-2016
Main Assets and Business of Da An Gene
Industrial Chain Layout of Da An Gene
Medical Resources of Sun Yat-Sen University
Da An Gene’s Revenue from Independent Clinical Laboratory and YoY Growth, 2010-2016
Revenue of Da An Gene from Top 5 Clients and % in Total Revenue, 2014-2015
Top 5 Suppliers of Da An Gene, 2014-2015
Revenue and Net Income of Da An Gene, 2015-2020E
Revenue and Net Income of Shanghai Labway, 2013-2016
Revenue Breakdown of Shanghai Labway by Product, 2013-2016
Gross Margin of Shanghai Labway by Product, 2013-2016
R&D Costs and % of Medical Diagnosis Service’s revenue of Nymphavn Biotechnology, 2013-2016
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Medicalsystem Biotechnology, 2013-2016
Revenue of Shanghai Labway’s Top 5 Clients and % in Total Revenue, 2013-2015
Revenue of Shanghai Labway’s Top 5 Clients and % in Total Revenue, 2015
Procurement of Shanghai Labway’ Top 5 Suppliers and % in Total Procurement, 2013-2015
Procurement of Shanghai Labway’ Top 5 Suppliers and % in Total Procurement, 2015
Revenue and Net Income of Nymphavn Biotechnology, 2009-2016
Revenue Breakdown of Nymphavn Biotechnology by Product, 2009-2016
Gross Margin of Nymphavn Biotechnology, 2009-2016
Gross Margin of Nymphavn Biotechnology by Product, 2009-2016
R&D Costs and % of Total Revenue of Nymphavn Biotechnology, 2011-2016
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Nymphavn Biotechnology, 2009-2016
Revenue and Net Income of Nymphavn Biotechnology, 2015-2020E
Subsidiaries and Main Businesses of Surexam Biotechnology
Revenue and Net Income of Surexam Biotechnology, 2011-2016
Revenue Breakdown of Surexam Biotechnology by Business, 2011-2016
Gross Margin of Surexam Biotechnology, 2011-2016
Gross Margin of Surexam Biotechnology by Product, 2009-2016
R&D Costs and % of Total Revenue of Surexam Biotechnology, 2011-2016
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Surexam Biotechnology, 2011-2016
Revenue of Surexam Biotechnology from Top 5 Clients and % of Total Revenue, 2015
Procurement of Surexam Biotechnology from Top 5 Suppliers and % of Total Procurement, 2015
Revenue and Net Income of Surexam Biotechnology, 2015-2020E
Revenue and Net Income of Medicalsystem Biotechnology, 2011-2016
Revenue Breakdown of Medicalsystem Biotechnology by Product, 2011-2016
Gross Margin of Medicalsystem Biotechnology by Product, 2011-2016
R&D Costs and % of Total Revenue of Medicalsystem Biotechnology, 2011-2016
Projects Proposed/Under Construction of Medicalsystem Biotechnology
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Medicalsystem Biotechnology, 2011-2016
Revenue of Medicalsystem Biotechnology’ Top 5 Clients and % in Total Revenue, 2011-2016
Procurement of Medicalsystem Biotechnology’ Top 5 Suppliers and % in Total Procurement, 2011-2016
Revenue and Net Income of Medicalsystem Biotechnology, 2015-2020E
Revenue and Net Income of Beijing Lawke, 2013-2016
Revenue Breakdown of Beijing Lawke by Region, 2014-2016
Gross Margin of Beijing Lawke by Business, 2013-2016
Revenue and Net Income of Beijing Lawke, 2015-2020E
Revenue and Net Income of Lepu Gene, 2013-2016
Gross Margin of Lepu Gene,2013-2016
Revenue and Net Income of Lepu Gene, 2015-2020E
Revenue and Net Income of Biotecan,2013-2016
Revenue Breakdown of Shanghai Biotecan by Business 2014-2016
Gross Margin of Shanghai Biotecan, 2014-2016
Clinical Laboratory Revenue of Shanghai Biotecan and % of Total Revenue, 2013-2016
Revenue and Net Income of Biotecan, 2015-2020E
Revenue and Net Income of Jiangsu Superbio, 2014-2015
Revenue Breakdown of JiangsuSuperbio by Business,2014-2015
Revenue Breakdown of S Jiangsu Superbio by Region,2014-2015
Gross Margin of Jiangsu Superb by business,2014-2015
Revenue of Jiangsu Superb from Top 5 Clients and % of Total Revenue, 2014-2015
Procurement of Jiangsu Superb from Top 5 Suppliers and % of Total Procurement, 2014-2015
Revenue and Net Income of Jiangsu Superbio, 2015-2020
Milestones of Kindstar Global
Some Strategic Partners of ADINOVO
Chinese Independent Clinical Laboratory Market Size and YoY Growth, 2014-2020E
Revenue of Major Independent Clinical Laboratory Enterprises in China, 2011-2016
Clinical Laboratory Revenue of Major Enterprises in Independent Clinical Laboratory Industry in China, 2012-2016
Gross Margin of Major Enterprises in Independent Clinical Laboratory Industry in China, 2012-2016
Gross Margin of Clinical Laboratory Business of Major Independent Clinical Laboratory Enterprises in China, 2012-2016

  • Flow Cytometry Market Players--Market Shares by Country, and Strategic Assessments of Major Suppliers and Emerging Market Entrants
    Published: 14-Sep-2017        Price: US 2450 Onwards        Pages: 25
    This new report from LeadingMarketResearch.com provides strategic assessments of leading and emerging flow cytometry market players. The report presents strategic analyses of major current and emerging manufacturers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 25 pages......
  • Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 18500 Onwards        Pages: 358
    Complete report $18,500. DataPack (test volumes, sales forecasts, supplier shares) $7,400.This 7-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of ......
  • Europe Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 13700 Onwards        Pages: 270
    This unique report provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.This 5-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future marketing and t......
  • France Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 146
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the French flow cytometry market, including:Major issues pertaining to the French flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for major......
  • Germany Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 147
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the German flow cytometry market, including:Major issues pertaining to the German flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for major......
  • Italy Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 142
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the Italian flow cytometry market, including:Major issues pertaining to the Italian flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for maj......
  • Japan Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 4900 Onwards        Pages: 142
    Complete report $4,900. DataPack (test volumes, sales forecasts, supplier shares) $3,200.This report presents a comprehensive analysis of the Japanese flow cytometry market, including:Major issues pertaining to the Japanese flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for m......
  • Spain Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 140
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the Spanish flow cytometry market, including:Major issues pertaining to the Spanish flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for maj......
  • UK Flow Cytometry Market 2021: Reagents and Instruments Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    Published: 13-Sep-2017        Price: US 3900 Onwards        Pages: 146
    Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.This report presents a comprehensive analysis of the UK flow cytometry market, including:Major issues pertaining to the UK flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five-year volume and sales forecasts for major flow cy......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs